Mrvová Silvia, Frydrýšková Klára, Pospíšek Martin, Vopálenský Václav, Mašek Tomáš
Department of Genetics and Microbiology, Faculty of Science, Charles University, Viničná 5, 128 44, Prague, Czech Republic.
Mol Genet Genomics. 2018 Feb;293(1):167-186. doi: 10.1007/s00438-017-1375-4. Epub 2017 Sep 23.
Alternative polyadenylation is an important and pervasive mechanism that generates heterogeneous 3'-termini of mRNA and is considered an important regulator of gene expression. We performed bioinformatics analyses of ESTs and the 3'-UTRs of the main transcript splice variants of the translational initiation factor eIF4E1 and its family members, eIF4E2 and eIF4E3. This systematic analysis led to the prediction of new polyadenylation signals. All identified polyadenylation sites were subsequently verified by 3'RACE of transcripts isolated from human lymphoblastic cell lines. This led to the observation that multiple simultaneous polyadenylation site utilization occurs in single cell population. Importantly, we described the use of new polyadenylation site in the eIF4E1 mRNA, which lacked any known polyadenylation signal. The proportion of eIF4E1 transcripts derived from the first two polyadenylation sites in eIF4E1 mRNA achieved 15% in a wide range of cell lines. This result demonstrates the ubiquitous presence of ARE-lacking transcripts, which escape HuR/Auf1-mediated control, the main mechanism of eIF4E1 gene expression regulation. We found many EST clones documenting the significant production of transcript variants 2-4 of eIF4E2 gene that encode proteins with C-termini that were distinct from the mainly studied prototypical isoform A. Similarly, eIF4E3 mRNAs are produced as two main variants with the same very long 3'-UTR with potential for heavy post-transcriptional regulation. We identified sparsely documented transcript variant 1 of eIF4E3 gene in human placenta. eIF4E3 truncated transcript variants were found mainly in brain. We propose to elucidate the minor splice variants of eIF4E2 and eIF4E3 in great detail because they might produce proteins with modified features that fulfill different cellular roles from their major counterparts.
可变聚腺苷酸化是一种重要且普遍存在的机制,它能产生mRNA的异质3'末端,被认为是基因表达的重要调节因子。我们对翻译起始因子eIF4E1及其家族成员eIF4E2和eIF4E3的主要转录本剪接变体的ESTs和3'-UTR进行了生物信息学分析。这种系统分析导致了新聚腺苷酸化信号的预测。随后,通过对从人淋巴母细胞系分离的转录本进行3'RACE,验证了所有鉴定出的聚腺苷酸化位点。这导致观察到在单细胞群体中存在多个同时使用的聚腺苷酸化位点。重要的是,我们描述了eIF4E1 mRNA中一个新的聚腺苷酸化位点的使用情况,该位点缺乏任何已知的聚腺苷酸化信号。在广泛的细胞系中,eIF4E1 mRNA前两个聚腺苷酸化位点产生的转录本比例达到了15%。这一结果表明缺乏ARE的转录本普遍存在,它们逃避了HuR/Auf1介导的控制,而这是eIF4E1基因表达调控的主要机制。我们发现许多EST克隆记录了eIF4E2基因转录本变体2 - 4的大量产生,这些变体编码的蛋白质C末端与主要研究的原型异构体A不同。同样,eIF4E3 mRNA作为两种主要变体产生,具有相同的非常长的3'-UTR,具有大量转录后调控的潜力。我们在人胎盘中鉴定出了记录稀少且有文献记载的eIF4E3基因转录本变体1。eIF4E3截短的转录本变体主要在大脑中发现。我们建议详细阐明eIF4E2和eIF4E3的小剪接变体,因为它们可能产生具有修饰特征的蛋白质,这些蛋白质履行与其主要对应物不同的细胞功能。